Levocetirizin Bluefish

Levocetirizine Dihydrochloride, the active ingredient in Levocetirizin Bluefish, is an antihistamine presented as an oral tablet for oral use. It relieves symptoms of allergic rhinitis, chronic urticaria and other IgE‑mediated allergic conditions in adults and children as directed by a prescriber.

GNH USA supplies Levocetirizin Bluefish as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizine is an antihistamine that acts on the histamine H1‑receptor pathway to control allergic disease. - Allergic rhinitis: reduces nasal congestion, sneezing and itching. - Chronic idiopathic urticaria: diminishes hives and associated pruritus. - Seasonal allergic conjunctivitis: alleviates eye itching and redness.

Adverse reactions may occur with any antihistamine therapy. Most are mild and reversible.

Common Side Effects: - Drowsiness: mild to moderate sedation, especially after the first dose. - Headache: transient, usually resolves without intervention. - Dry mouth: decreased salivation, can be managed with hydration. - Fatigue: general tiredness that improves with continued use. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips or throat requiring urgent care. - Anaphylaxis: severe allergic reaction with respiratory compromise. - Stevens‑Johnson syndrome: rare severe skin eruption. - Hepatic dysfunction: abnormal liver enzymes in isolated cases. - Cardiac arrhythmia: rare reports of QT prolongation.

Before initiating therapy, consider patient‑specific factors and safety measures. - Renal function: assess in severe impairment; dose may need adjustment. - Sedation: avoid operating machinery until individual response is known. - Alcohol: limit intake as combined effect may increase drowsiness. - Pediatric use: not recommended for children under six years without specialist advice. - Hypersensitivity: discontinue if rash, swelling or breathing difficulty develop. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Levocetirizine may interact with other medicines that influence sedation or hepatic metabolism.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): can raise levocetirizine plasma levels. - Alcohol: additive central nervous system depression. - Other H1‑antihistamines: may cause excessive sedation.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampicin): may reduce therapeutic effect. - Theophylline: levocetirizine can increase theophylline concentrations. - CNS depressants (e.g., benzodiazepines): may enhance drowsiness. - Anticholinergic agents: may worsen dry mouth.